Skip to content
StockMarketAgent
Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

NEO/HELP stock hub

NEO/HELP has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

NEO/HELPis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
363.7M
Cboe Canada
Market data

Live price

Current market quote for this ticker.

Current price
NEO/HELP
In the news

Latest news · NEO/HELP

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 11P50 15.6P75 25.4
Trailing P/En/a
P25 7.4P50 15.6P75 34.3
ROE-55.9
P25 -121.5P50 -40.9P75 0.5
ROIC-33.8
P25 -72.5P50 -16P75 1.4
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All NEO/HELP market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
149
Groups with data
11
Currency
USD
Showing 149 of 149 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

19
MetricValue
Country
Canada
Country code
CA
Employees
50
Employees Change
0%
Employees Change Percent
0
Enterprise value
CAD 96.6M
Exchange
Cboe Canada
Financial currency
USD
First seen
2026-05-10
Industry
Biotechnology
Isin
CA23256X4075
Last refreshed
2026-05-10
Market cap
CAD 363.7M
Price
CAD 7.25
Price currency
CAD
Sector
Healthcare
Sic
2834
Symbol
neo/HELP
Website
https://cybin.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

5
MetricValue
Earnings Yield
-46.45%
EV Earnings
-0.57x
EV/FCF
-0.62x
FCF yield
-43.02%
P/B ratio
0.97x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

8
MetricValue
Net Income
CAD -168.9M
Profit Per Employee
CAD -3.4M
ROA
-31.95
Roa5y
-38.58
ROCE
-43.51
ROE
-55.89
Roe5y
-64.39
ROIC
-33.79

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

3
MetricValue
Cagr1y
-15.02%
Cagr3y
-24.01%
Cagr5y
-27.31%

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

16
MetricValue
Assets
CAD 397.8M
Cash
CAD 267.5M
Current Assets
CAD 304.7M
Current Liabilities
CAD 22.1M
Equity
CAD 375.6M
Interest Coverage
-40.86
Liabilities
CAD 22.2M
Long Term Assets
CAD 93.1M
Long Term Liabilities
CAD 65,844
Net Cash
CAD 267.5M
Net Cash By Market Cap
CAD 73.56
Net Cash Growth
106%
Net Debt Equity
CAD -0.71
Tangible Book Value
CAD 283.7M
Tangible Book Value Per Share
CAD 5.69
WACC
8.7

Liquidity

Current-asset coverage and working-capital efficiency metrics.

4
MetricValue
Current ratio
13.78
Net Working Capital
CAD 15.9M
Quick ratio
12.36
Working Capital
CAD 283.4M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

3
MetricValue
Buyback Yield
-49.68%
Dividend per share
CAD 0
Last Dividend
CAD 0

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

35
MetricValue
1Y total return
-15.01%
200-day SMA
8.84
3Y total return
-56.13%
50-day SMA
7.36
50-day SMA vs 200-day SMA
50under200
5Y total return
-79.7%
All Time High
136
All Time High Change
-94.67%
All Time High Date
2021-08-31
All Time Low
5.9
All Time Low Change
22.88%
All Time Low Date
2026-03-31
ATR
0.51
Beta
0.81
Ch YTD
-34.74
High
7.3
High52
12.7
High52 Date
2025-12-30
High52ch
-42.91%
Low
7.1
Low52
5.9
Low52 Date
2026-03-31
Low52ch
22.88%
Ma50ch
-1.49%
Price vs 200-day SMA
-17.99%
RSI
49.23
RSI Monthly
40.81
RSI Weekly
43.79
Sharpe ratio
0.09x
Sortino ratio
0.19
Total Return
-49.68%
Tr YTD
-34.74
Tr1m
-0.55%
Tr1w
3.57%
Tr3m
-10.93%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

1
MetricValue
Operating Income
CAD -163.4M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
34,241,795%
Net Borrowing
33,285,608.7
Shares Insiders
1.7%
Shares Institutions
34.19%
Shares Qo Q
75.67%
Shares Yo Y
49.68%
Short Ratio
2.81

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

48
MetricValue
Adjusted FCF
CAD -166.1M
Average Volume
20,966.7x
Bv Per Share
7.53
CAPEX
CAD -2.5M
Ch1m
-0.55
Ch1w
3.57
Ch1y
-15.01
Ch3m
-10.93
Ch3y
-56.13
Ch5y
-79.7
Ch6m
-16.38
Change
-0.28%
Change From Open
-0.68
Close
7.27
Days Gap
0.41
Depreciation Amortization
-83,541.8
Dollar Volume
126,063
Earnings Date
2026-07-01
EBIT
CAD -163.4M
EBITDA
CAD -163.5M
EPS
CAD -6.14
F Score
2
FCF
CAD -156.5M
FCF EV Yield
-161.97x
Financing CF
293,019,722
Fiscal Year End
March
Goodwill
50,021,726.6
Investing CF
-2,513,078
Is Primary Listing
0
Last Earnings Date
2026-02-13
Last Report Date
2025-12-31
Last Split Date
2024-09-19
Last Split Type
Reverse
Ma150
8.63
Ma150ch
-15.99%
Ma20
7.35
Ma20ch
-1.37%
Net CF
146,404,609
Next Earnings Date
2026-07-01
Open
7.3
Position In Range
75
Ppne
254,271.3
Price Date
2026-05-08
Ptbv Ratio
1.28
Relative Volume
0.83x
Share Based Comp
9,664,601
Tr6m
-16.38%
Volume
17,388
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does NEO/HELP pay a dividend?

Capital-return profile for this ticker.

Performance

NEO/HELP stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-15.0%
S&P 500 1Y: n/a
3Y total return
-56.1%
S&P 500 3Y: n/a
5Y total return
-79.7%
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns NEO/HELP?

Insider, institutional, and short-interest positioning.

Institutional ownership
+34.2%
Share of float held by funds and institutions
Insider ownership
+1.7%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
2.8 days to cover
Y/Y dilution
+49.7%
Negative means the company is buying back shares.
Technical

NEO/HELP momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
49.2
Neutral momentum band
Price vs 200-day MA
-18.0%
50/200-day relationship not available
Beta (5Y)
0.81
Moves roughly with the market
Sharpe ratio
0.09
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About NEO/HELP

Hub-level FAQ points readers to the deeper analysis pages.

What is the current neo/HELP stock rating?

neo/HELP is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full neo/HELP analysis?

The full report lives at /stocks/neo/HELP/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for neo/HELP?

The latest report frames neo/HELP around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the neo/HELP page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.